AU7053494A - Method of treating coronary vascular disease using docosahexaenoic acid - Google Patents

Method of treating coronary vascular disease using docosahexaenoic acid

Info

Publication number
AU7053494A
AU7053494A AU70534/94A AU7053494A AU7053494A AU 7053494 A AU7053494 A AU 7053494A AU 70534/94 A AU70534/94 A AU 70534/94A AU 7053494 A AU7053494 A AU 7053494A AU 7053494 A AU7053494 A AU 7053494A
Authority
AU
Australia
Prior art keywords
vascular disease
docosahexaenoic acid
treating coronary
coronary vascular
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70534/94A
Inventor
David John Kyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Martek Biosciences Corp
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Publication of AU7053494A publication Critical patent/AU7053494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU70534/94A 1993-06-04 1994-06-02 Method of treating coronary vascular disease using docosahexaenoic acid Abandoned AU7053494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7093093A 1993-06-04 1993-06-04
US070930 1993-06-04
PCT/US1994/006316 WO1994028891A1 (en) 1993-06-04 1994-06-02 Method of treating coronary vascular disease using docosahexaenoic acid

Publications (1)

Publication Number Publication Date
AU7053494A true AU7053494A (en) 1995-01-03

Family

ID=22098214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70534/94A Abandoned AU7053494A (en) 1993-06-04 1994-06-02 Method of treating coronary vascular disease using docosahexaenoic acid

Country Status (2)

Country Link
AU (1) AU7053494A (en)
WO (1) WO1994028891A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122405A (en) * 1995-06-07 2003-04-10 Martek Biosciences Corp Methods for preparation of pharmaceutical composition for treatment of specific diseases using oils enriched in dha
GB9901809D0 (en) 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
JP2003048831A (en) 2001-08-02 2003-02-21 Suntory Ltd Composition having preventing and ameliorating action on symptom or disease caused by decrease in brain function
JP4993852B2 (en) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 Composition having a preventive or ameliorating effect on symptoms or diseases accompanied by behavioral abnormalities caused by stress
JP5967855B2 (en) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 Composition having an activity of reducing daytime activity and / or depressive symptoms
US8383677B2 (en) 2006-12-28 2013-02-26 Suntory Holdings Limited Nerve-regenerating agent
US20110236476A1 (en) 2008-09-02 2011-09-29 Amarin Corporation Plc. Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
BRPI1007518A2 (en) 2009-02-10 2018-02-20 Amarin Pharma, Inc. use of ethyl ester eicopentanoic acid for treatment of hypertriglyceridemia
CA2759284C (en) 2009-04-29 2016-06-21 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
BRPI1014405A2 (en) 2009-04-29 2016-04-05 Amarin Corp Plc pharmaceutical compositions comprising epa and a cardiovascular agent and methods of their use
ES2661217T3 (en) 2009-06-15 2018-03-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods to reduce triglycerides without increasing LDL-C levels in a subject in simultaneous statin therapy
RU2012116079A (en) 2009-09-23 2013-10-27 АМАРИН КОРПОРЕЙШН ПиЭлСи PHARMACEUTICAL COMPOSITION, INCLUDING OMEGA-3 FATTY ACID AND HYDROXY DERIVATED STATIN AND WAYS OF ITS APPLICATION
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP2646013A4 (en) 2010-11-29 2014-03-26 Amarin Pharma Inc Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
JP6307442B2 (en) 2012-01-06 2018-04-04 アマリン ファーマシューティカルス アイルランド リミテッド Compositions and methods for reducing the level of high sensitivity (HS-CRP) in a subject
PL3363433T3 (en) 2012-06-29 2021-06-14 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy using eicosapentaenoic acid ethyl ester
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
EP2958982B1 (en) 2013-12-20 2019-10-02 Mara Renewables Corporation Methods of recovering oil from microorganisms
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
TW201900160A (en) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 Compositions and Methods for Lowering Triglycerides in a Subject Having Reduced Kidney Function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
TN2021000013A1 (en) 2018-09-24 2022-10-03 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of cardiovascular events in a subject
KR20240012390A (en) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 How to Reduce Your Risk of Heart Failure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
US5130242A (en) * 1988-09-07 1992-07-14 Phycotech, Inc. Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US5012761A (en) * 1988-11-17 1991-05-07 Oh Suk Y Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs

Also Published As

Publication number Publication date
WO1994028891A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
AU7053494A (en) Method of treating coronary vascular disease using docosahexaenoic acid
AU629388B2 (en) An expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses
AU7734391A (en) Essential fatty acid treatment
AU5276393A (en) Compositions containing esters of unsaturated fatty acids
IL117417A0 (en) Method of treating cardiac inflammatory disease
AU1415792A (en) Method to diagnose heart and coronary artery disease
AU2187992A (en) Composition and method for disease treatment
AUPN271295A0 (en) Method of treatment
AU659456B2 (en) Fatty acid treatment
AU1111492A (en) Method of treating type i diabetes
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU8676898A (en) Endovascular coronary sinus catheter and method of use
AU6819394A (en) Method of joining portions of inflation catheter
AU1111592A (en) Method of treating type i diabetes
AU2685892A (en) Method of treating blood
AU3861989A (en) Method for the treatment and the diagnosis of coronary heart disease
AU7623694A (en) Method of producing liquor
EP0809505A4 (en) Method of treating chronic progressive vascular diseases
PL308300A1 (en) Method of hydroxycarbonylating pentenic acids
AU8058194A (en) A pharmaceutical composition for the treatment of coronary thrombosis
AU7483194A (en) Fatty acid anhydride process
AU7999691A (en) Phthalamic acids and their isomers for treating leukotriene-related diseases
AU7389496A (en) Methods and compositions for treating vascular stenosis
EP0552019A3 (en) Method of producing 1,4-dihydroxy-2-naphthoic acid
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.